Detalhe da pesquisa
1.
Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant-ineligible patients with myeloma who are treated with bortezomib-based induction.
Eur J Haematol
; 107(4): 497-499, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34129711
2.
The first known case of vaccine-induced thrombotic thrombocytopenia in Australia.
Med J Aust
; 215(1): 19-20.e1, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34117641
3.
TOP2A expression predicts responsiveness to carfilzomib in myeloma and informs novel combinatorial strategies for enhanced proteasome inhibitor cell killing.
Leuk Lymphoma
; 62(2): 337-347, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33131357
4.
DNA-Repair Gene Mutations Are Highly Prevalent in Circulating Tumour DNA from Multiple Myeloma Patients.
Cancers (Basel)
; 11(7)2019 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31261969
5.
Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients.
Leukemia
; 33(8): 2022-2033, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30992504
6.
Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma.
Blood Cancer J
; 13(1): 25, 2023 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781844
7.
The impact of G-CSF alone vs G-CSF and cyclophosphamide mobilisation on autograft immune cell content in multiple myeloma.
Bone Marrow Transplant
; 57(6): 1001-1003, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35352035
8.
Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies.
Cancer Biol Med
; 13(2): 215-25, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27458529
9.
Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol.
Leuk Lymphoma
; 55(12): 2801-7, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24528220
10.
Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse.
Leuk Lymphoma
; 54(2): 336-41, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22812445